Market closed

MoonLake Immunotherapeutics/$MLTX

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

Ticker

$MLTX
Trading on

Industry

Biotechnology

Headquarters

Zug, Switzerland

Employees

100

MLTX Metrics

BasicAdvanced
$2.4B
-
-$1.89
1.31
-
$2.4B
1.31
$58.26
$31.42
489K
21.113
20.071
0.321
0.624
-17.81%
-25.08%
5.31
5.31
-20.186
158.08%
-38.69%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $MLTX

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs

What’s the current market cap for MoonLake Immunotherapeutics stock?

What is the P/E ratio for MoonLake Immunotherapeutics stock?

Does MoonLake Immunotherapeutics stock pay dividends?

When is the next MoonLake Immunotherapeutics dividend payment date?

What is the beta indicator for MoonLake Immunotherapeutics?